The deadline for research-based drug manufacturers to submit an intended price increase for their products in 2010 to the Conseil du médicament is Friday, January 8, 2010 4:30 p.m. The maximum price increase allowed in 2010 (based on the change in Quebec's annual CPI) is limited to 0.48%. According to the Politique du médicament, the guaranteed selling price for generic products must not exceed 60% (first generic product) and 54% (subsequent generic products) of the brand price. Price increase requests must be sent either by e-mail (cdm-prix@msss.gouv.qc.ca) , by fax (418.528.2622), or by mail (Conseil du médicament, Direction scientifique de l’inscription - PRIX 2010, 1195, avenue Lavigerie, 1er étage, Bureau 100, Québec (Québec), G1V 4N3).
Please consult the Conseil’s website for more details on filing requirements.
NOVA SCOTIA
Nova Scotia has released the November Pharmacists’ Bulletin Volume 09-10. Highlights include new products added to the Nova Scotia Formulary.
ONTARIO
Ontario has released Update N and Update N1 to the ODB Formulary, effective November 19, 2009.
BRITISH COLUMBIA
BC PharmaCare Newsletter Edition 09-016 has been released. Highlights include New Limited Coverage Benefits and Criteria Changes.
BC PharmaCare Newsletter Edition 09-017 has been released. Highlights include Olanzapine – Specific Products no Longer Eligible for PharmaCare Coverage.
BC PharmaCare Newsletter Edition 09-018 has been released. Highlights include Flu Clinic Locator Website.
CADTH
CADTH has released COMPUS Communiqué Volume 5, Number 5. Highlights include Final Reports on Self-Monitoring of Blood Glucose Now Available.
CADTH has released COMPUS Communiqué Volume 5, Number 6. Highlights include Executive Summary for Self-Monitoring of Blood Glucose.
CADTH has released Technology Report Issue 122: Long-Acting Beta2-Agonist and Inhaled Corticosteroid Combination Therapy for Adult Persistent Asthma: Systematic Review of Clinical Outcomes and Economic Evaluation.
CADTH has released an HTA Discussion Paper: Reassesment of Health Technologies: Obsolescence and Waste.
CADTH has released Health Technology Update Issue 12. Highlights include Informing Decision-Makers About Emerging Medical Technologies, Policies, Practices and Research.
CADTH has released a Health Technology Assessment Rapid Review: Portable Monitoring Devices for Diagnosis of Obstructive Sleep Apnea at Home: Review of Accuracy, Cost-Effectiveness, Guidelines, and Coverage in Canada.
CADTH has released CDR Update Issue 63. Highlights include Consultations on Patient Input.
CADTH has released CDR Update Issue 64 . Highlights include Fixed Dose Combinations – Consultation.
